Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healios KK Ord Shs HLOSF

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.


PINL:HLOSF - Post by User

Post by sweenbyon Nov 04, 2010 7:24pm
294 Views
Post# 17660835

Article

Article

Halo Resources: Sherridon’s Value Can Be Seen in HudBay Deal

by Karl Loomescompany news image

Sometimes, a misconception by the market can lead a strong, well managed company, to be undervalued. Worse still for an investor, a misconception can often hide facts and figures that would show the potential for value growth at the company. In late 2009, Halo Resources (TSX-V: HLO) entered into an option agreement with HudBay Minerals (TSX: HBM) allowing HudBay to earn a 67.5% joint venture interest in part of their flagship Sherridon Volcanogenic Massive Sulphide (VMS) property, and since this point the market has generally seemed to misconceive the nature of this agreement.

This option agreement was on 1.1 square kilometers of the Sherridon property. The total Sherridon property is around 200 square kilometers in size. This option agreement effectively has very minimal ‘dilution’ of future revenue and cash flows from the property, representing only a tiny portion of the total land package that Halo hold. Furthermore, rather than somehow decreasing the value of the property, if anything it should act as an indicator to the market for the potential of the property. If just one square kilometre of the property was able to raise C$6.3 million in work commitments and payouts, not even considering the value of the metal in the ground, then consider the potential multiplier for a property 200 square kilometers in size.

<< Previous
Bullboard Posts
Next >>